Viral Mimicry Revealed: SARS-CoV-2 T Cells Also Recognize Tumor Antigens
Single-cell TCR sequencing shows that SARS-CoV-2-specific CD8 T cells recognize a tumor-associated antigen through molecular mimicry, supporting viral-mimic cancer vaccines.
Single-cell TCR sequencing shows that SARS-CoV-2-specific CD8 T cells recognize a tumor-associated antigen through molecular mimicry, supporting viral-mimic cancer vaccines.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.